Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia

Clinical trial NCT04275245 · COMPLETED

Trial details

NCT number: NCT04275245
Sponsor: Tang-Du Hospital
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Coronavirus Disease 2019 (COVID-19)

Start date: 2020-02-03
Primary completion: 2020-03-09
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.